Cargando…
Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort
OBJECTIVES: Persistent post-acute coronavirus disease 2019 (COVID-19) symptoms (PACSs) have been reported up to 6 months after hospital discharge. Herein we assessed the symptoms that persisted 12 months (M12) after admission for COVID-19 in the longitudinal prospective national French coronavirus d...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523945/ https://www.ncbi.nlm.nih.gov/pubmed/36191847 http://dx.doi.org/10.1016/j.cmi.2022.08.028 |
_version_ | 1784800400483811328 |
---|---|
author | Ghosn, Jade Bachelet, Delphine Livrozet, Marine Cervantes-Gonzalez, Minerva Poissy, Julien Goehringer, François Gandonniere, Charlotte Salmon Maillet, Mylène Bani-Sadr, Firouzé Martin-Blondel, Guillaume Tattevin, Pierre Launay, Odile Surgers, Laure Dudoignon, Emmanuel Liegeon, Geoffroy Zucman, David Joseph, Cédric Senneville, Eric Yelnik, Cécile Roger, Pierre-Marie Faure, Karine Gousseff, Marie Cabié, André Duval, Xavier Chirouze, Catherine Laouénan, Cédric |
author_facet | Ghosn, Jade Bachelet, Delphine Livrozet, Marine Cervantes-Gonzalez, Minerva Poissy, Julien Goehringer, François Gandonniere, Charlotte Salmon Maillet, Mylène Bani-Sadr, Firouzé Martin-Blondel, Guillaume Tattevin, Pierre Launay, Odile Surgers, Laure Dudoignon, Emmanuel Liegeon, Geoffroy Zucman, David Joseph, Cédric Senneville, Eric Yelnik, Cécile Roger, Pierre-Marie Faure, Karine Gousseff, Marie Cabié, André Duval, Xavier Chirouze, Catherine Laouénan, Cédric |
author_sort | Ghosn, Jade |
collection | PubMed |
description | OBJECTIVES: Persistent post-acute coronavirus disease 2019 (COVID-19) symptoms (PACSs) have been reported up to 6 months after hospital discharge. Herein we assessed the symptoms that persisted 12 months (M12) after admission for COVID-19 in the longitudinal prospective national French coronavirus disease cohort. METHODS: Hospitalized patients with a confirmed virological diagnosis of COVID-19 were enrolled. Follow-up was planned until M12 after admission. Associations between persistence of ≥3 PACSs at M12 and clinical characteristics at admission were assessed through logistic regression according to gender. RESULTS: We focused on participants enrolled between 24 January 2020 and 15 July 2020, to allow M12 follow-up. The M12 data were available for 737 participants. Median age was 61 years, 475 (64%) were men and 242/647 (37%) were admitted to intensive care units during the acute phase. At M12, 27% (194/710) of the participants had ≥3 persistent PACS, mostly fatigue, dyspnoea and joint pain. Among those who had a professional occupation before the acute phase, 91 out of 339 (27%) were still on sick leave at M12. Presence of ≥3 persistent PACS was associated with female gender, both anxiety and depression, impaired health-related quality of life and Medical Muscle Research Council Scale <57. Compared with men, women more often reported presence of ≥3 persistent PACSs (98/253, 39% vs. 96/457, 21%), depression and anxiety (18/152, 12% vs. 17/268, 6% and 33/156, 21% vs. 26/264, 10%, respectively), impaired physical health-related quality of life (76/141, 54% vs. 120/261, 46%). Women had less often returned to work than men (77/116, 66% vs. 171/223, 77%). CONCLUSIONS: One fourth of the individuals admitted to hospital for COVID-19 still had ≥3 persistent PACSs at M12 post-discharge. Women reported more often ≥3 persistent PACSs, suffered more from anxiety and depression and had less often returned to work than men. |
format | Online Article Text |
id | pubmed-9523945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95239452022-09-30 Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort Ghosn, Jade Bachelet, Delphine Livrozet, Marine Cervantes-Gonzalez, Minerva Poissy, Julien Goehringer, François Gandonniere, Charlotte Salmon Maillet, Mylène Bani-Sadr, Firouzé Martin-Blondel, Guillaume Tattevin, Pierre Launay, Odile Surgers, Laure Dudoignon, Emmanuel Liegeon, Geoffroy Zucman, David Joseph, Cédric Senneville, Eric Yelnik, Cécile Roger, Pierre-Marie Faure, Karine Gousseff, Marie Cabié, André Duval, Xavier Chirouze, Catherine Laouénan, Cédric Clin Microbiol Infect Original Article OBJECTIVES: Persistent post-acute coronavirus disease 2019 (COVID-19) symptoms (PACSs) have been reported up to 6 months after hospital discharge. Herein we assessed the symptoms that persisted 12 months (M12) after admission for COVID-19 in the longitudinal prospective national French coronavirus disease cohort. METHODS: Hospitalized patients with a confirmed virological diagnosis of COVID-19 were enrolled. Follow-up was planned until M12 after admission. Associations between persistence of ≥3 PACSs at M12 and clinical characteristics at admission were assessed through logistic regression according to gender. RESULTS: We focused on participants enrolled between 24 January 2020 and 15 July 2020, to allow M12 follow-up. The M12 data were available for 737 participants. Median age was 61 years, 475 (64%) were men and 242/647 (37%) were admitted to intensive care units during the acute phase. At M12, 27% (194/710) of the participants had ≥3 persistent PACS, mostly fatigue, dyspnoea and joint pain. Among those who had a professional occupation before the acute phase, 91 out of 339 (27%) were still on sick leave at M12. Presence of ≥3 persistent PACS was associated with female gender, both anxiety and depression, impaired health-related quality of life and Medical Muscle Research Council Scale <57. Compared with men, women more often reported presence of ≥3 persistent PACSs (98/253, 39% vs. 96/457, 21%), depression and anxiety (18/152, 12% vs. 17/268, 6% and 33/156, 21% vs. 26/264, 10%, respectively), impaired physical health-related quality of life (76/141, 54% vs. 120/261, 46%). Women had less often returned to work than men (77/116, 66% vs. 171/223, 77%). CONCLUSIONS: One fourth of the individuals admitted to hospital for COVID-19 still had ≥3 persistent PACSs at M12 post-discharge. Women reported more often ≥3 persistent PACSs, suffered more from anxiety and depression and had less often returned to work than men. European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023-02 2022-09-30 /pmc/articles/PMC9523945/ /pubmed/36191847 http://dx.doi.org/10.1016/j.cmi.2022.08.028 Text en © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Ghosn, Jade Bachelet, Delphine Livrozet, Marine Cervantes-Gonzalez, Minerva Poissy, Julien Goehringer, François Gandonniere, Charlotte Salmon Maillet, Mylène Bani-Sadr, Firouzé Martin-Blondel, Guillaume Tattevin, Pierre Launay, Odile Surgers, Laure Dudoignon, Emmanuel Liegeon, Geoffroy Zucman, David Joseph, Cédric Senneville, Eric Yelnik, Cécile Roger, Pierre-Marie Faure, Karine Gousseff, Marie Cabié, André Duval, Xavier Chirouze, Catherine Laouénan, Cédric Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort |
title | Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort |
title_full | Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort |
title_fullStr | Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort |
title_full_unstemmed | Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort |
title_short | Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort |
title_sort | prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523945/ https://www.ncbi.nlm.nih.gov/pubmed/36191847 http://dx.doi.org/10.1016/j.cmi.2022.08.028 |
work_keys_str_mv | AT ghosnjade prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT bacheletdelphine prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT livrozetmarine prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT cervantesgonzalezminerva prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT poissyjulien prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT goehringerfrancois prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT gandonnierecharlottesalmon prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT mailletmylene prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT banisadrfirouze prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT martinblondelguillaume prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT tattevinpierre prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT launayodile prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT surgerslaure prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT dudoignonemmanuel prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT liegeongeoffroy prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT zucmandavid prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT josephcedric prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT sennevilleeric prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT yelnikcecile prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT rogerpierremarie prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT faurekarine prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT gousseffmarie prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT cabieandre prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT duvalxavier prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT chirouzecatherine prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT laouenancedric prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort AT prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort |